Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02193854
Other study ID # TaipeiMU
Secondary ID
Status Completed
Phase N/A
First received June 9, 2014
Last updated July 16, 2014
Start date September 2013
Est. completion date January 2014

Study information

Verified date July 2014
Source Taipei Medical University
Contact n/a
Is FDA regulated No
Health authority Mongolia: Ethics Committee
Study type Interventional

Clinical Trial Summary

Objective This study is aimed to estimate the distance, time and the cost of travel saved by patients who are seeking tele-dermatology (TD) service though smart mobile phones in the resource poor settings at the rural clinics of Mongolia.

Methods A cluster-randomised trial was conducted for six months at the 20 rural health clinics selected from three districts in Mongolia. With a computer-generated sequence, health clinics were randomly allocated either to the intervention group, in which all general practitioners (GPs) received TD consultation through Sana system, or the control group, in which GPs referred patients to the dermatologist at district hospital whenever needed. The primary outcome was to estimate the distance traveled, times spend and the cost of travel required in receiving dermal care for patients in rural Mongolia. Analysis was done to estimate the difference between the aforementioned parameters among intervention and control groups.


Description:

The investigators used Sana system, that is a mobile phone-based, open source software platform for telemedicine services. The Android-based system supports multimedia, location-based data, and text. In the village health clinic, a healthcare worker will interact with a patient and collects data through a step-by-step clinical questionnaire on a smart mobile phone. As patients' data is uploaded to an open source electronic medical record system (OpenMRS) with a diagnosis-specific information and images. The consultant can access the clinical information about the patient and make appropriate diagnoses and treatment recommendations from the secondary hospital.


Recruitment information / eligibility

Status Completed
Enrollment 441
Est. completion date January 2014
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients aged 18-98 years visiting with dermal problem.

Exclusion Criteria:

- Patients who do not need dermal care.

- Patients who are already under treatment for dermal problem.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Device:
Mobile Phone
Investigators used Sana system, that is a mobile phone-based, open source software platform for telemedicine services. The Android-based system supports multimedia, location-based data, and text. In the village health clinic, a healthcare worker will interact with a patient and collects data through a step-by-step clinical questionnaire on a smart mobile phone. As patients' data is uploaded to an open source electronic medical record system (OpenMRS) with a diagnosis-specific information and images. The consultant can access the clinical information about the patient and make appropriate diagnoses and treatment recommendations from the secondary hospital.

Locations

Country Name City State
Taiwan Shabbir Syed Abdul Taipei

Sponsors (2)

Lead Sponsor Collaborator
Taipei Medical University Health Science University of Mongolia

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison between the number of referrals in the control and intervention groups Outcome measures are the number of referrals done in the control and in the intervention groups. We compared the difference in the number of referrals with Sana system and without. up to 5 months Yes
Secondary Satisfaction by physicians and patients by questionnaire Both physicians and patients who were in the intervention group were satisfied by the Sana system. up to 5 months No
See also
  Status Clinical Trial Phase
Withdrawn NCT04555122 - COVID-19 Ad Intervention N/A
Completed NCT04378452 - Assessment of the Psycho-social Impact of COVID-19 Outbreak
Recruiting NCT04487171 - Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic N/A